CORONA Quarterly Results, Profit & Loss, Balance Sheet (CORONA)

CORONA quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • CORONA Financials
  • CORONA Shareholding Pattern
  • CORONA Earnings Documents
  • CORONA Announcements
  • CORONA Corporate Actions
  • CORONA Bulk, Block & Insider Deals
  • CORONA Delivery Data
  • CORONA Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Corona Remedies Ltd (CORONA) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Corona Remedies Ltd reported sales of ₹441 Cr, operating profit of ₹96 Cr (OPM 22%) and net profit of ₹60 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

CORONA quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales298294347361342353422441
Expenses228239277283259291329345
Operating Profit6954707883629396
OPM23%18%20%22%24%18%22%22%
Other Income1222-17433
Interest22222133
Depreciation1010999101315
Profit before tax5844617055558081
Tax23%28%24%25%25%17%25%25%
Net Profit4532465241456060
EPS in Rs7.355.167.558.556.757.419.839.86
CORONA profit & loss, annual (₹ Cr)
MetricMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales8841,0141,1961,4031,559
Expenses7568599561,1091,225
Operating Profit128156241294334
OPM14%15%20%21%21%
Other Income756-9-7
Interest4141178
Depreciation2028373848
Profit before tax111118199240271
Tax23%24%25%23%-
Net Profit8590149185207
EPS in Rs13.8914.824.4330.2733.85
Dividend Payout20%25%30%33%-
CORONA balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital6161616161
Reserves419545598686744
Borrowings1598663165115
Other Liabilities191237254293326
Total Liabilities8319309771,2051,247
Fixed Assets384370394554698
CWIP12118620514322
Investments26260260
Other Assets301348378482526
Total Assets8319309771,2051,247
CORONA cash flows (₹ Cr)
MetricMar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity103157190229
Cash from Investing Activity-50-267-84-256
Cash from Financing Activity-4599-10725
Net Cash Flow8-110-1
Free Cash Flow9-1299956
CFO/OP100%112%97%95%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit1001129795
CORONA ratios
MetricMar 2023Mar 2024Mar 2025Mar 2026
Debtor Days36363638
Inventory Days182158200175
Days Payable163184221206
Cash Conversion Cycle5510147
Working Capital Days30-29-15
ROCE-25%32%33%
  • CORONA Shareholding Pattern
  • CORONA Earnings Concalls
  • CORONA Growth Catalysts
  • CORONA Corporate Actions
  • CORONA Announcements
  • CORONA Results & Documents
  • CORONA Bulk & Block Deals
  • CORONA Delivery Data